S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
Log in
CVE:ICO

iCo Therapeutics Inc. (ICO.V) Stock Forecast, Price & News

C$0.06
-0.01 (-7.69 %)
(As of 01/20/2021 02:42 PM ET)
Add
Compare
Today's Range
C$0.06
Now: C$0.06
C$0.07
50-Day Range
C$0.00
MA: C$0.05
C$0.07
52-Week Range
C$0.02
Now: C$0.06
C$0.08
Volume241,653 shs
Average Volume1.21 million shs
Market CapitalizationC$9.22 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.

MarketRank

Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-6029414
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.00 per share
Book ValueC$0.00 per share

Profitability

Miscellaneous

Market CapC$9.22 million
Next Earnings Date5/21/2021 (Estimated)
OptionableNot Optionable
C$0.06
-0.01 (-7.69 %)
(As of 01/20/2021 02:42 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ICO News and Ratings via Email

Sign-up to receive the latest news and ratings for ICO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











iCo Therapeutics Inc. (ICO.V) (CVE:ICO) Frequently Asked Questions

How has iCo Therapeutics Inc. (ICO.V)'s stock price been impacted by COVID-19 (Coronavirus)?

iCo Therapeutics Inc. (ICO.V)'s stock was trading at C$0.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ICO shares have increased by 33.3% and is now trading at C$0.06.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than iCo Therapeutics Inc. (ICO.V)?

Wall Street analysts have given iCo Therapeutics Inc. (ICO.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but iCo Therapeutics Inc. (ICO.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is iCo Therapeutics Inc. (ICO.V)'s next earnings date?

iCo Therapeutics Inc. (ICO.V) is scheduled to release its next quarterly earnings announcement on Friday, May 21st 2021.
View our earnings forecast for iCo Therapeutics Inc. (ICO.V)
.

How were iCo Therapeutics Inc. (ICO.V)'s earnings last quarter?

iCo Therapeutics Inc. (ICO.V) (CVE:ICO) issued its quarterly earnings data on Tuesday, November, 24th. The company reported ($0.01) EPS for the quarter.
View iCo Therapeutics Inc. (ICO.V)'s earnings history
.

Who are some of iCo Therapeutics Inc. (ICO.V)'s key competitors?

What other stocks do shareholders of iCo Therapeutics Inc. (ICO.V) own?

Who are iCo Therapeutics Inc. (ICO.V)'s key executives?

iCo Therapeutics Inc. (ICO.V)'s management team includes the following people:
  • Mr. William Wasyl Jarosz, Chairman & CEO (Age 64)
  • Ms. Susan L. Koppy, Pres & Director (Age 58, Pay $52.49k)
  • Mr. Michael Liggett B.Sc., C.A., C.P.A., CPA, CA, Bsc. Pharm., CFO, Corp. Sec. & Director (Age 60, Pay $42.45k)
  • Dr. Peter Hnik, Chief Medical Officer & Director (Age 64)

What is iCo Therapeutics Inc. (ICO.V)'s stock symbol?

iCo Therapeutics Inc. (ICO.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ICO."

How do I buy shares of iCo Therapeutics Inc. (ICO.V)?

Shares of ICO and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is iCo Therapeutics Inc. (ICO.V)'s stock price today?

One share of ICO stock can currently be purchased for approximately C$0.06.

How big of a company is iCo Therapeutics Inc. (ICO.V)?

iCo Therapeutics Inc. (ICO.V) has a market capitalization of C$9.22 million.

What is iCo Therapeutics Inc. (ICO.V)'s official website?

The official website for iCo Therapeutics Inc. (ICO.V) is www.icotherapeutics.com.

How can I contact iCo Therapeutics Inc. (ICO.V)?

iCo Therapeutics Inc. (ICO.V)'s mailing address is 760-777 Hornby St, VANCOUVER, BC V6Z 1S4, Canada. The company can be reached via phone at +1-604-6029414.

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.